CLCS — Cell Source Balance Sheet
0.000.00%
- $16.02m
- $2.18m
Annual balance sheet for Cell Source, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 0.028 | 0.245 | 0.093 | 0.223 | 0.022 |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 0.115 | 0.452 | 0.314 | 0.41 | 0.195 |
| Other Long Term Assets | |||||
| Total Assets | 0.115 | 0.452 | 0.314 | 0.41 | 0.195 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 5.71 | 8.4 | 10.1 | 13 | 15.8 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Liabilities | 5.86 | 8.4 | 10.1 | 13 | 15.8 |
| Redeemable Preferred Stock | |||||
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | -5.74 | -7.95 | -9.83 | -12.6 | -15.6 |
| Total Liabilities & Shareholders' Equity | 0.115 | 0.452 | 0.314 | 0.41 | 0.195 |
| Total Common Shares Outstanding | |||||
| Total Preferred Shares Outstanding |